Communicators

EnWave Appoints Brent Charleton as Senior Vice President, Sales and Business Development and Announces Retirement of Bino Anand

Vancouver, B.C., September 29, 2017

EnWave Corporation (TSX-V:ENW | FSE:E4U) (“EnWave”, or the "Company" - http://www.commodity-tv.net/c/search_adv/?v=297827) announced today that Brent Charleton, CFA, has been appointed as Senior Vice President, Sales and Business Development. This appointment consolidates the role of Senior Vice President, Sales previously held by Bino Anand, who will be retiring from EnWave. EnWave would like to thank Mr. Anand for his many years of service to the Company.

Mr. Charleton joined EnWave in 2010 and has led the Company’s proactive business development efforts. In this expanded role, Mr. Charleton will further accelerate EnWave’s sales and business development strategy to secure additional purchase orders and licenses for the use of EnWave’s Radiant Energy Vacuum (“REV™”) dehydration technology. The Company intends to add additional sales professionals to broaden the ongoing effort to deploy new REV™ machines and to drive growth in its royalty revenue portfolio.

About EnWave

EnWave Corporation, a Vancouver-based advanced technology company, has developed Radiant Energy Vacuum (“REV™”) – an innovative, proprietary method for the precise dehydration of organic materials. REV™ technology’s commercial viability has been demonstrated and is growing rapidly across several market verticals in the food and pharmaceutical sectors. EnWave’s strategy is to sign royalty-bearing commercial licenses with industry leaders in multiple verticals for the use of REV™ technology. The company has signed twenty-two royalty-bearing licenses to date, opening up eight distinct market sectors for commercialization of new and innovative products. In addition to these licenses, EnWave has formed a Limited Liability Partnership, NutraDried LLP, to develop, manufacture, market and sell all-natural cheese snack products in the United States under the Moon Cheese® brand.

EnWave has introduced REV™ as the new dehydration standard in the food and biological material sectors: faster and cheaper than freeze drying, with better end product quality than air drying or spray drying. EnWave currently has three commercial REV™ platforms:

1. nutraREV® which is used in the food industry to dry food products quickly and at low-cost, while maintaining high levels of nutrition, taste, texture and colour;

2. powderREV® which is used for the bulk dehydration of food cultures, probiotics and fine biochemicals such as enzymes below the freezing point, and

3. quantaREV® which is used for continuous, high-volume low-temperature drying.

An additional platform, freezeREV®, is being developed as a new method to stabilize and dehydrate biopharmaceuticals such as vaccines and antibodies. More information about EnWave is available at www.enwave.net.

 EnWave Corporation

Dr. Tim Durance

President & CEO

For further information:

John Budreski, Executive Chairman at +1 (416) 930-0914
E-mail: jbudreski@enwave.net

Brent Charleton, Senior Vice President, Sales and Business Development at +1 (778) 378-9616
E-mail: bcharleton@enwave.net   

Deborah Honig, Corporate Development, Adelaide Capital Markets at + 1 (604) 755-1348

E-mail: dhonig@enwave.net
 

Jeremy Hellman, Senior Associate, The Equity Group at +1 (212) 836-9626

E-mail: jhellman@equityny.com

EnWave Corporation

Suite 425 – 744 West Hastings St.

Vancouver, B.C., CANADA V6C 1A5

Tel (604) 806-6110

Fax (604) 806-6112

TSX Venture Exchange trading symbol: ENW

www.enwave.net

Safe Harbour for Forward-Looking Information Statements: This press release may contain forward-looking information based on management's expectations, estimates and projections. All statements that address expectations or projections about the future, including statements about the Company's strategy for growth, product development, market position, expected expenditures, and the expected synergies following the closing are forward-looking statements. All third party claims referred to in this release are not guaranteed to be accurate. All third party references to market information in this release are not guaranteed to be accurate as the Company did not conduct the original primary research. These statements are not a guarantee of future performance and involve a number of risks, uncertainties and assumptions. Although the Company has attempted to identify important factors that could cause actual results to differ materially, there may be other factors that cause results not to be as anticipated, estimated or intended. There can be no assurance that such statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward-looking statements.

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.